Small-cell lung cancer (SCLC) is an aggressive cancer with limited treatment options. Nearly all cases show deregulation in cell cycle progression, a therapeutic vulnerability that can be exploited.

Lung adenocarcinoma (LUAD) is the most common form of lung cancer, accounting for nearly half of cases. Many patients are ...

A new preliminary study published in Nature suggests that COVID-19 vaccines might actually boost the immune system to make ...

From the 2010s to the present, the existing technologies in the clinic and operating room have been improved with the goals ...

Presentations feature data from first-in-human Phase 1 study including Cyclin E1 biomarker findings, supporting late-stage development of azenosertib ...

Rhabdomyosarcoma (RMS) accounts for up to 10% of childhood cancers and nearly half of pediatric soft tissue sarcomas.

BERLIN -- After multiple failed attempts, an immune checkpoint inhibitor has broken through and landed a significant overall ...

As the Israeli Hamas ceasefire appears to be holding, Palestinians are grappling with what comes next in their quest for ...